135 related articles for article (PubMed ID: 25614175)
1. Plasma pro-surfactant protein B and lung function decline in smokers.
Leung JM; Mayo J; Tan W; Tammemagi CM; Liu G; Peacock S; Shepherd FA; Goffin J; Goss G; Nicholas G; Tremblay A; Johnston M; Martel S; Laberge F; Bhatia R; Roberts H; Burrowes P; Manos D; Stewart L; Seely JM; Gingras M; Pasian S; Tsao MS; Lam S; Sin DD;
Eur Respir J; 2015 Apr; 45(4):1037-45. PubMed ID: 25614175
[TBL] [Abstract][Full Text] [Related]
2. Pro-surfactant protein B as a biomarker for lung cancer prediction.
Sin DD; Tammemagi CM; Lam S; Barnett MJ; Duan X; Tam A; Auman H; Feng Z; Goodman GE; Hanash S; Taguchi A
J Clin Oncol; 2013 Dec; 31(36):4536-43. PubMed ID: 24248694
[TBL] [Abstract][Full Text] [Related]
3. Budesonide/formoterol enhances the expression of pro Surfactant Protein-B in lungs of COPD patients.
Um SJ; Lam S; Coxson H; Man SF; Sin DD
PLoS One; 2013; 8(12):e83881. PubMed ID: 24386300
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in COPD: the search continues!
Mannino DM
Eur Respir J; 2015 Apr; 45(4):872-4. PubMed ID: 25829429
[No Abstract] [Full Text] [Related]
5. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
[TBL] [Abstract][Full Text] [Related]
6. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
[TBL] [Abstract][Full Text] [Related]
7. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
8. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
9. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
10. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
Pirozzi CS; Gu T; Quibrera PM; Carretta EE; Han MK; Murray S; Cooper CB; Tashkin DP; Kleerup EC; Barjaktarevic I; Hoffman EA; Martinez CH; Christenson SA; Hansel NN; Graham Barr R; Bleecker ER; Ortega VE; Martinez FJ; Kanner RE; Paine R;
Respir Res; 2018 Nov; 19(1):223. PubMed ID: 30454050
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms of SFTPB rs7316, rs9752 and PAOX rs1046175 affect the diagnostic value of plasma Pro-SFTPB and DAS in Chinese Han non-small-cell lung cancer patients.
Wang K; Huang Q; Zhao G; Yang J; Yang K; Huang Y
J Cell Biochem; 2019 Sep; 120(9):14804-14812. PubMed ID: 31016788
[TBL] [Abstract][Full Text] [Related]
12. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
[TBL] [Abstract][Full Text] [Related]
13. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
15. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for FEV
Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
[TBL] [Abstract][Full Text] [Related]
17. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.
Oh YM; Jeong BH; Woo SY; Kim SY; Kim H; Lee JH; Lim SY; Rhee CK; Yoo KH; Lee JH; Yoon HK; Sin DD; Lee SD; Kim EK; Park HY;
Ann Am Thorac Soc; 2015 Jul; 12(7):1005-12. PubMed ID: 26010877
[TBL] [Abstract][Full Text] [Related]
18. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts.
Tho NV; Ryujin Y; Ogawa E; Trang le TH; Kanda R; Goto K; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
Respirology; 2015 May; 20(4):594-601. PubMed ID: 25788016
[TBL] [Abstract][Full Text] [Related]
19. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
Coxson HO; Dirksen A; Edwards LD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Crim C; Duvoix A; Fauerbach PN; Lomas DA; Macnee W; Mayer RJ; Miller BE; Müller NL; Rennard SI; Silverman EK; Tal-Singer R; Wouters EF; Vestbo J;
Lancet Respir Med; 2013 Apr; 1(2):129-36. PubMed ID: 24429093
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
